Skip to content

Intra-arterial t-PA infusion during mechanical thrombectomy in acute ischemic stroke: a randomized trial.

Status
Not yet recruiting
Phases
Phase 3
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2023-510374-13-00
Acronym
Vanish Trial
Enrollment
120
Registered
2024-05-13
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

People with acute ischemic stroke (AIS) due to large vessel occlusion of the anterior circulation.

Brief summary

The proportion of patients achieving a mRS 0-1

Detailed description

The proportion of patients with dramatic clinical recovery (DCR). DCR will be defined as a decrease of ≥8 points from baseline NIHSS or a 24-hour NIHSS score ≤2., The proportion of patients achieving a mRS 0-2, The proportion of hemorrhagic complications. A non-contrast CT will be performed after 24 to 48 hours to evaluate the presence and degree of hemorrhagic transformation according to the ECASS-II criteria[3]., The proportion of symptomatic intracerebral hemorrhage (sICH), The proportion of death due to any cause, The proportion of patients who suffer a Safety Outcome. Safety outcome will be defined as the proportion of patients with the composite of: (i) symptomatic intracranial hemorrhage (ii) major bleeding due to access complications including groin hematoma, retroperitoneal hematoma (iii) contrast nephropathy., The proportion of patients discharged at home with or without services

Interventions

Sponsors

Vall D'hebron Institut De Recerca
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Design outcomes

Primary

MeasureTime frame
The proportion of patients achieving a mRS 0-1

Secondary

MeasureTime frame
The proportion of patients with dramatic clinical recovery (DCR). DCR will be defined as a decrease of ≥8 points from baseline NIHSS or a 24-hour NIHSS score ≤2., The proportion of patients achieving a mRS 0-2, The proportion of hemorrhagic complications. A non-contrast CT will be performed after 24 to 48 hours to evaluate the presence and degree of hemorrhagic transformation according to the ECASS-II criteria[3]., The proportion of symptomatic intracerebral hemorrhage (sICH), The proportion of death due to any cause, The proportion of patients who suffer a Safety Outcome. Safety outcome will be defined as the proportion of patients with the composite of: (i) symptomatic intracranial hemorrhage (ii) major bleeding due to access complications including groin hematoma, retroperitoneal hematoma (iii) contrast nephropathy., The proportion of patients discharged at home with or without services

Countries

Spain

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026